Stockscreener 앱 받기
202.73
2.50%
4.94
시간 외 거래:
202.73
전일 마감가:
$197.79
열려 있는:
$196.63
하루 거래량:
1.22M
Relative Volume:
1.04
시가총액:
$28.73B
수익:
$2.31B
순이익/손실:
$-208.16M
주가수익비율:
-131.93
EPS:
-1.5366
순현금흐름:
$76.11M
1주 성능:
+6.53%
1개월 성능:
-6.30%
6개월 성능:
+11.94%
1년 성능:
+34.37%
1일 변동 폭
$196.00
$204.34
1주일 범위
$187.01
$204.34
52주 변동 폭
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
202.73 | 28.03B | 2.31B | -208.16M | 76.11M | -1.5366 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | Citigroup | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-27 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 재개 | Wells Fargo | Equal Weight |
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Groupama Asset Managment Has $12.42 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Jonathan Sheena files Rule 144 notice selling shares (NASDAQ: NTRA) - Stock Titan
Natera, Inc. (NTRA) reports preliminary Q4 revenue - MSN
Faithward Advisors LLC Invests $3.52 Million in Natera, Inc. $NTRA - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Buys 17,100 Shares of Natera, Inc. $NTRA - MarketBeat
JP Morgan lifts Natera, Inc. (NTRA) target on Signatera momentum - MSN
Insider Selling: Natera (NASDAQ:NTRA) Director Sells 122 Shares of Stock - MarketBeat
Natera director Chapman sells $23348 in shares - Investing.com
Natera director Chapman sells $23348 in shares By Investing.com - Investing.com Australia
Natera (NTRA) director sells 122 shares under 10b5-1 trading plan - Stock Titan
Natera Looks Compelling As Oncology Testing Momentum Keeps Building (NASDAQ:NTRA) - Seeking Alpha
Natera named Healthcare Technology Company of the Year - The Healthcare Technology Report.
Assessing Natera (NTRA) Valuation After New Signatera Data And Zenith Genomics Launch - simplywall.st
Holocene Advisors LP Decreases Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Boothbay Fund Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat
Natera executive chairman sells $38.3 million in NTRA stock - Investing.com
Natera executive chairman sells $38.3 million in NTRA stock By Investing.com - Investing.com Canada
NeoGenomics, Natera, and Amphastar Pharmaceuticals Stocks Soar—Key Information You Should Be Aware Of - Bitget
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
Natera (NTRA) chair Rabinowitz exercises options and sells 200,000 shares - Stock Titan
NeoGenomics, Natera, and Amphastar Pharmaceuticals shares skyrocket, what you need to know - MSN
Why Natera Stock Is Surging On Fresh Optimism - TipRanks
NTRA Debuts Zenith Genomics Next-Gen Sequencing Test for Rare Diseases - Yahoo Finance
Natera (NTRA) Highlights Promising Results for Signatera in Canc - GuruFocus
Natera ctDNA test shows promise in anal, rectal cancer studies - Investing.com
Natera ctDNA test shows promise in anal, rectal cancer studies By Investing.com - Investing.com India
Fred Alger Management LLC Buys 41,303 Shares of Natera, Inc. $NTRA - MarketBeat
Farallon Capital Management LLC Sells 568,357 Shares of Natera, Inc. $NTRA - MarketBeat
Cancer DNA test ties anal and rectal tumors to relapse odds - Stock Titan
Natera launches whole genome sequencing test for rare diseases - Investing.com Nigeria
Coatue Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Capital Impact Advisors LLC Boosts Stock Position in Natera, Inc. $NTRA - MarketBeat
Aquatic Capital Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat
Pinnbrook Capital Management LP Makes New $5.78 Million Investment in Natera, Inc. $NTRA - MarketBeat
Guidance Update: Can Natera Inc keep up with sector leadersPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
[144] Natera, Inc. SEC Filing - Stock Titan
Natera Launches Zenith Genomics To Expand Rare Disease Testing Story - simplywall.st
Zenith Genomics Launch Could Be A Game Changer For Natera’s (NTRA) Rare Disease Strategy - Yahoo Finance
Meridiem Capital Partners LP Invests $11.90 Million in Natera, Inc. $NTRA - MarketBeat
Quantitative Investment Management LLC Acquires 6,152 Shares of Natera, Inc. $NTRA - MarketBeat
16,650 Shares in Natera, Inc. $NTRA Purchased by Magnetar Financial LLC - MarketBeat
Korea Investment CORP Cuts Position in Natera, Inc. $NTRA - MarketBeat
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - Sahm
MyOme Debuts Zenithtm Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - lelezard.com
GeneDx stock falls as Natera launches competing rare disease test - Investing.com UK
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Natera announces commercial launch of Zenith genomics - TipRanks
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis - BioSpace
MyOme Debuts Zenith Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - Finviz
Natera, Inc. $NTRA Shares Sold by Swiss National Bank - MarketBeat
New genome test from Natera and MyOme targets 5-year rare disease delays - Stock Titan
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.53%
0.33%
자본화:
|
볼륨(24시간):